Lantern Pharma Q3 Results: Steady Financial Gains, Stock Jumps
Lantern Pharma, a pioneering artificial intelligence (“AI”) company specializing in targeted and transformative cancer therapies, unveiled its financial results for the third quarter (Q3) ending
